BOSTON & BRAINTREE, Mass. & CAMBRIDGE, Mass. & SOMERVILLE, Mass. & QUINCY, Mass.--(BUSINESS WIRE)--On Monday, June 4, as part of BIO 2018 and the Massachusetts Biotech Ecosystem Tours, the Life Sciences Corridor, a partnership created by the mayors of Boston, Braintree, Cambridge, Quincy and Somerville, will conduct bus tours exploring these biotechnology hubs and several of the life sciences companies driving innovation.
Boston will conduct two tours: one includes the South Boston Waterfront District, and the other includes the Longwood Medical Area and Fenway. The South Boston Waterfront District offers a dynamic mix of opportunities and spaces, drawing on burgeoning technology, biotech and design communities. At the heart of this area is District Hall, the world’s first civic innovation center. This interdisciplinary community is home to GE headquarters and MassChallenge, the most startup-friendly accelerator in the world. Boston’s Longwood Medical and Academic Area is a thriving community of medical, academic, research and cultural organizations, home to over 57,000 scientists, researchers and staff, and over 29,000 students. The LMA is one of the densest medical clusters in the United States. The tour will include a site visit to Dana-Farber Cancer Institute’s recently completed research facility.
The town of Braintree’s tour will highlight why two global companies, Haemonetics and Citra Labs, chose Braintree’s proximity to the intellectual capital of the Greater Boston area - geographic advantages, transportation assets available for product distribution and employee commutes are reasons for calling Braintree home.
Cambridge will conduct two tours: one includes exploration of LabCentral Pfizer and the other includes Kendall Square MIT’s Koch Institute. On one tour you will learn how LabCentral, a co-working launch-pad builds successful environments for biotech startups and has become the international model for co-working in the life sciences. Also, discover how public-private partnerships fuel these destinations and build the base for economic development as a part of this system, and how universities and large institutions play a critical role. The other Cambridge tour will stop at MIT’s Koch Institute featuring a panel with Nobel prize winner Dr. Phillip A. Sharp, a world leader in molecular biology and biochemistry; Dr. Angela Belcher, a leading biological engineer, and Dr. Anne Deconinck, executive director of the Koch Institute.
The development of Quincy Center into a medical and research area is underway. The city has designated FoxRock Co. as the developer of over 1M square-feet in the city and has plans for medical users with lab/office space. Quincy has garnered more than $225M in private investment for new residential units supported by $200M in State/Federal funds solely for infrastructure to accommodate the new and exciting development in the City of Presidents.
Visit Assembly Square to see an innovative model of mixed-use development in Somerville, one of the area's most creative and exciting cities just over a mile from downtown Boston and Kendall Square on public transit. Assembly Square, winner of Curbed Boston's "Neighborhood of the Year" award two years running, is anchored by Partners HealthCare, the largest network of hospitals and physicians' groups in the state, with 4,500 employees in a state-of-the-art headquarters.
Tours will run from 11:30 a.m. to 4:30 p.m. and registration is $35. Attendees should meet at the Boston Convention and Exhibition Center, Room 160BC. Deadline to register is May 18. For more information and to register, visit: https://bio.swoogo.com/biotours
About the Life Sciences Corridor
Formed in 2014, the Life Sciences Corridor is a partnership created by the mayors of Boston, Cambridge, Quincy, Somerville and Braintree. The Corridor is focused on promoting the robust life sciences sector along the MBTA red line in the Greater Boston region. The initiative harnesses the resources of the cities, individually and collectively, to foster continued success in research, innovation and business development. For more information, visit lifesciencescorridor.com.